Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same, much prefer it this way. The scumbags will always be here. At least now they don’t go totally unchecked on their garbage.
FDA update the timeframes or something? Link the sauce
Looks like Hikma has the first approval and 180 days Vyvanse generic exclusivity starting tomorrow, actually. 8/24/23
The OG Poorme is back in the call center and Jammy is on light desk duty after a particularly difficult goat.
Lol right? Stock has doubled or even tripled depending on which low point you look at earlier this year.
Run of the mill FUD and not even particularly good at it.
Lol I would take that bet.
You would agree though that strategically, if it helps us get a better market position for these larger drugs, even if withholding trial results to do so, that’s ultimately a net positive for Elite, right?
No reason to assume they failed. Similar to how they didn’t PR the insufflation results, they may be holding the cards on this close to the chest while they prepare the filing. Nasrat did mention on the last call - “we’ll announce filings and approvals.” Something like that.
I hoped they would release the results but if these CNS ANDAs are what we think they are, that means these are billion or multi-billion dollar drug markets. If them keeping a low profile is to establish a better market position at and after launch, I’m fine with that. More revenues should drive the price higher down the road than announcing trial results now, honestly.
Talking to yourself again? Weird
Low energy
Short cat is admittedly outta the bag now lol
Might as well cover, hang it up and move on
“All I have to do is figure out how to cover 16m share short”
Hopefully you go absolutely broke covering too.
No chance.
Almost 4 million volume in the first 30 minutes.
Sure beats the hell out of 10k shares traded for the whole day, 90k shares the whole day… :)
Sounds like that might’ve been the case with multiple partners. Nasrat specifically called out ones like TAGI, made it sound like they pull their weight and maybe we want to keep some of those arrangements in place.
Good to have a lot of our drugs being sold on our label by Kirko, sounds like he’s able to squeeze out more $ on both our larger and smaller generics.
Whew that’s a juicy one. We’ll hear about it upon filing at the very least.
Haha desperate
Should be in good shape either way it shakes out.
Pretty wild how some stocks are valued vs others. Elite has such a long and complex history - used to just burn cash with little to show for it. Voluntarily delisted from the NYSE Amex in 2009.
The ART tech is still there in the background but the company has successfully reinvented itself as primarily a profitable generic drug maker now.
But of course Kcidstae already knows all that. They were assigned here a long time ago to try and drive the price down and scare other investors away. Pathetic.
Bonus clown points for them basically saying I was stupid for buying 6 cent ELTP shares too. LOL. (I bought lower but even the assumption is still stupid)
Over 800k volume in the first 10 minutes lol. Not complaining!
It’s not filed yet so nothing to reject. They just got the results. Assuming positive, still usually takes a couple months or so to file the ANDA application with the FDA.
@jour_trader I hope not. Yikes.
Wonder how long the current financial consultants situation stays in place before hiring next permanent CFO. I don’t blame Nasrat for joking around saying maybe he’ll wait awhile since the stock finally rose some. Lol
K swimfan. Lol.
Now keep liking and responding. You won’t stop, because you’ve been obsessing over me for a year+ now.
Now keep proving me right. LOL
Actually pretty sure this one in particular has nothing to do with ELTP, at least initially. Just here to harass because I post here, been posing as me on multiple other platforms. Disgruntled player from a previous online game that has made its life mission to stalk since about July of ‘22.
But yes, sprinkle in a few random comments to act normal, try to blend in. lol.
Ya he does. Lol. Here and on multiple other platforms. The question is why would I randomly make that up?
But hey, don’t take my word for it - just check my post history. Why else would the same person like every. single. post. that I’ve made since February? Hmm. Even posts like “lol”.
Swimfan
Definitely in a good spot either way it goes. We know it’s in the hopper in any case.
Someone else made a good point - with SequestOx being the lone exception because they didn’t re-submit due to further trials being cost prohibitive, Elite has gotten approval on every drug they’ve ever filed with the FDA.
Good DD. Hopefully we get a PR with a juicy IQVIA number tomorrow or Tuesday.
Sure I traded a few. Hilarious that you think you know anything beyond what I said. LOL.
You’re so pissed that this company and stock didn’t die like all the other ones whose boards you harass like a plague. I’m loving it!
Now stick around and tell us how bad it is that the stock is rising. LOLOLOL.
Hey Sharpei, been a long time. Hope you’ve been well!
Welcome back.
And probably an approval of the dopamine agonist in October? Filed 12/22/22 or thereabouts. Not a needle mover but every bit helps.
My guess would be if approved in Oct/Nov 2023, maybe launch in Jan/Feb 2024?
https://elite.irpass.com/Elite-Pharmaceuticals-Files-ANDA-with-US-FDA-to-Market-Dopamine-Agonist-12-22-2022
Holy shit this volume lol
Didn’t we have like 90k volume total on some days in the past?
Kcidstae calling in all the reserves huh, five alarm fire in the boiler
Agreed. Idea behind the buyback was reduce the OS and improve the stock performance from all-time-lows.
If that happens organically as it seems to be now? Then so be it.
Think it was just the lull we had to get through as they pivoted from full-bore ART to building the full pipeline of generics at all stages of the approval process. Now finally seeing the blooming of the planted seeds.
Still don’t think the stock was ever truly “worth” as low as mid 2s, should’ve been higher all along.
Welcome aboard the positive train!!!!!!!
:)
Same. ;(
Hahahah scramble!!! Call in reinforcements!!
Impotent
Nothing to save, hundreds of thousands of shares been on lock for awhile. News flash - you can be both a long term holder and trade a portion of your holdings.
But simpletons can’t hold two ideas in their head simultaneously I guess.
Impotent